The global medical device clinical trials market size is evaluated at USD 17.74 billion in 2025 and is forecasted to hit around USD 30.53 billion by 2034, growing at a CAGR of 6.22% from 2025 to 2034. The North America market size was accounted at USD 7.35 billion in 2024 and is expanding at a CAGR of 6.33% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Medical Device Clinical Trials Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Medical Device Clinical Trials Market, by Study Type
8.1.1 Feasibility and Pilot Study
8.1.1.1. Market Revenue and Forecast
8.1.2. Pivotal Study
8.1.2.1. Market Revenue and Forecast
8.1.3. FDA PMA Application
8.1.3.1. Market Revenue and Forecast
8.1.4. Post-Approval Study
8.1.4.1. Market Revenue and Forecast
9.1. Medical Device Clinical Trials Market, by Study Design
9.1.1. Interventional
9.1.1.1. Market Revenue and Forecast
9.1.2. Observational
9.1.2.1. Market Revenue and Forecast
9.1.3. Expanded Access
9.1.3.1. Market Revenue and Forecast
10.1. Medical Device Clinical Trials Market, by Indication
10.1.1. Cardiovascular devices
10.1.1.1. Market Revenue and Forecast
10.1.2. Neurology devices
10.1.2.1. Market Revenue and Forecast
10.1.3. Orthopedic devices
10.1.3.1. Market Revenue and Forecast
10.1.4. Diagnostic imaging
10.1.4.1. Market Revenue and Forecast
10.1.5. Anesthesia and Respiratory devices
10.1.5.1. Market Revenue and Forecast
10.1.5. Others
10.1.5.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Study Type
11.1.2. Market Revenue and Forecast, by Study Design
11.1.3. Market Revenue and Forecast, by Indication
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Study Type
11.1.4.2. Market Revenue and Forecast, by Study Design
11.1.4.3. Market Revenue and Forecast, by Indication
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Study Type
11.1.5.2. Market Revenue and Forecast, by Study Design
11.1.5.3. Market Revenue and Forecast, by Indication
11.2. Europe
11.2.1. Market Revenue and Forecast, by Study Type
11.2.2. Market Revenue and Forecast, by Study Design
11.2.3. Market Revenue and Forecast, by Indication
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Study Type
11.2.4.2. Market Revenue and Forecast, by Study Design
11.2.4.3. Market Revenue and Forecast, by Indication
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Study Type
11.2.5.2. Market Revenue and Forecast, by Study Design
11.2.5.3. Market Revenue and Forecast, by Indication
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Study Type
11.2.6.2. Market Revenue and Forecast, by Study Design
11.2.6.3. Market Revenue and Forecast, by Indication
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Study Type
11.2.7.2. Market Revenue and Forecast, by Study Design
11.2.7.3. Market Revenue and Forecast, by Indication
11.3. APAC
11.3.1. Market Revenue and Forecast, by Study Type
11.3.2. Market Revenue and Forecast, by Study Design
11.3.3. Market Revenue and Forecast, by Indication
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Study Type
11.3.4.2. Market Revenue and Forecast, by Study Design
11.3.4.3. Market Revenue and Forecast, by Indication
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Study Type
11.3.5.2. Market Revenue and Forecast, by Study Design
11.3.5.3. Market Revenue and Forecast, by Indication
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Study Type
11.3.6.2. Market Revenue and Forecast, by Study Design
11.3.6.3. Market Revenue and Forecast, by Indication
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Study Type
11.3.7.2. Market Revenue and Forecast, by Study Design
11.3.7.3. Market Revenue and Forecast, by Indication
11.4. MEA
11.4.1. Market Revenue and Forecast, by Study Type
11.4.2. Market Revenue and Forecast, by Study Design
11.4.3. Market Revenue and Forecast, by Indication
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Study Type
11.4.4.2. Market Revenue and Forecast, by Study Design
11.4.4.3. Market Revenue and Forecast, by Indication
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Study Type
11.4.5.2. Market Revenue and Forecast, by Study Design
11.4.5.3. Market Revenue and Forecast, by Indication
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Study Type
11.4.6.2. Market Revenue and Forecast, by Study Design
11.4.6.3. Market Revenue and Forecast, by Indication
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Study Type
11.4.7.2. Market Revenue and Forecast, by Study Design
11.4.7.3. Market Revenue and Forecast, by Indication
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Study Type
11.5.2. Market Revenue and Forecast, by Study Design
11.5.3. Market Revenue and Forecast, by Indication
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Study Type
11.5.4.2. Market Revenue and Forecast, by Study Design
11.5.4.3. Market Revenue and Forecast, by Indication
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Study Type
11.5.5.2. Market Revenue and Forecast, by Study Design
11.5.5.3. Market Revenue and Forecast, by Indication
12.1. Medtron ic
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Siemens Healthineers AG
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Fresenius Medical Care AG
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. GE Healthcare
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Koninklijke Philips N.V.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Danaher Corporation
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Baxter
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Boston Scientific Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. F. Hoffmann La Roche
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample